Incyte Corp (INCY) concluded trading on Wednesday at a closing price of $80.95, with 5.15 million shares of worth about $417.1 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 51.28% during that period and on November 06, 2024 the price saw a gain of about 4.75%. Currently the company’s common shares owned by public are about 224.29M shares, out of which, 190.30M shares are available for trading.
Stock saw a price change of 9.50% in past 5 days and over the past one month there was a price change of 23.14%. Year-to-date (YTD), INCY shares are showing a performance of 28.92% which increased to 48.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $50.35 but also hit the highest price of $77.37 during that period. The average intraday trading volume for Incyte Corp shares is 1.80 million. The stock is currently trading 16.81% above its 20-day simple moving average (SMA20), while that difference is up 21.19% for SMA50 and it goes to 32.57% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Incyte Corp (NASDAQ: INCY) currently have 224.29M outstanding shares and institutions hold larger chunk of about 103.70% of that.
The stock has a current market capitalization of $15.60B and its 3Y-monthly beta is at 0.70. PE ratio of stock for trailing 12 months is 573.30, while it has posted earnings per share of $0.14 in the same period. Its PEG reads 18.41 and has Quick Ratio of 1.82 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INCY, volatility over the week remained 2.99% while standing at 2.44% over the month.
Stock’s fiscal year EPS is expected to drop by -64.09% while it is estimated to increase by 367.47% in next year. EPS is likely to shrink at an annualized rate of 31.14% for next 5-years, compared to annual growth of 38.99% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on October 29, 2024 offering a Buy rating for the stock and assigned a target price range of between $68 and $90 to it. Coverage by Wolfe Research stated Incyte Corp (INCY) stock as an Outperform in their note to investors on October 01, 2024, suggesting a price target of $84 for the stock. On September 18, 2024, Truist Downgrade their recommendations, while on July 02, 2024, BMO Capital Markets Downgrade their ratings for the stock with a price target of $48. Stock get a Hold rating from Deutsche Bank on May 23, 2024.
